In Brief: Baxter International
This article was originally published in The Gray Sheet
Baxter International: Appoints Kshitij Mohan to the newly created position of corporate VP, research and technical services, with responsibility for overseeing the firm's domestic and international research and advanced product development activities. Previously, he served as VP, scientific affairs for the firm's U.S. Healthcare business. Prior to joining Baxter in 1988, Mohan held various position within FDA's device center, including director of the Office of Science and Technology and acting director of the Office of Device Evaluation...
You may also be interested in...
Becton Dickinson will spend $1.2bn over the next four years to improve its drug-delivery device manufacturing capabilities. See what Eric Borin, president of BD, said about it here.
Pfizer is producing vaccine doses at scale now that it has buttoned down the manufacturing process.
In second letter this year targeting email communications, OPDP says that putting the methotrexate oral solution’s risk information below the signature block does not offer ‘prominence and readability’ comparable to the information on the drug’s effectiveness for the treatment of acute lymphoblastic leukemia that was in the body of the email.